Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study

CONCLUSIONS: Globally, SABA use/overuse is widespread and is the greatest contributor to the carbon footprint of respiratory treatment, regardless of the economic status of countries. Implementing evidence-based treatment recommendations, personalising treatment and reducing healthcare inequities, especially in LMICs, may improve disease control and patient outcomes, thereby reducing SABA overuse and associated carbon emissions beyond SABA use alone.PMID:37684493 | DOI:10.1007/s12325-023-02663-2
Source: Adv Data - Category: Epidemiology Authors: Source Type: research